1-4 of 4
Scott Antonia
Close
Sort by
Journal Articles

Seven Year Followup for Bystander Vaccine Therapy in Mantle Cell Lymphoma (MCL)

Bijal D. Shah, MD, Jianguo Tao, MD PhD, Paul A. Chervenick, MD, Marcie L Riches, MD MS, Javier Pinilla-Ibarz, MD PhD, Lynn C. Moscinski, MD, Scott Antonia, MD, Eduardo M. Sotomayor, MD, Sophie Dessureault, MD
Journal: Blood
Blood (2014) 124 (21): 3083.
https://doi.org/10.1182/blood.V124.21.3083.3083
Published: 2014
Journal Articles

Long Term Followup of Bystander Vaccine Therapy in Mantle Cell Lymphoma (MCL),

Bijal D. Shah, MD, Jianguo Tao, MD, PhD, Lubomir Sokol, MD, PhD, Paul A. Chervenick, MD, Marcie Tomblyn, MD, MS, Javier Pinilla-Ibarz, MD, PhD, Lynn Moscinski, MD, Scott Antonia, MD, Eduardo M. Sotomayor, Sophie Dessureault, MD
Journal: Blood
Blood (2011) 118 (21): 3720.
https://doi.org/10.1182/blood.V118.21.3720.3720
Published: 2011
Journal Articles

Enhanced Immunological Responses Following K562/GM-CSF/CD40L Vaccine Plus Lenalidomide in High-Risk Myelodysplastic Syndrome

John Powers, B.S., Eric Padron, MD, Jason Dubovsky, Ph.D, Emmanuel Berchmans, B.S., Tyler Farnum, Fanqi Bai, MD, Eva Sahakian, Ph.D, Jamil Ahmed, Rami S. Komrokji, MD, Jeffrey E. Lancet, MD, Alan F. List, MD, Douglas G McNeel, MD, Sophie Dessureault, MD, Scott Antonia, MD, Eduardo M. Sotomayor, P.K. Epling-Burnette, PharmD, PhD, Javier Pinilla-Ibarz, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1725.
https://doi.org/10.1182/blood.V118.21.1725.1725
Published: 2011
Journal Articles

A Phase I Pilot Study of Bystander Vaccine and Lenalidomide Immune Augmentation In Patients with Myelodysplastic Syndrome (MDS)

Eric Padron, MD, Rami S. Komrokji, MD, Jeffrey E. Lancet, MD, Alan F. List, MD, Sophie Dessureault, Scott Antonia, Jamil Ahmed, Shiddhi Patel, John Powers, Fanqi Bai, Eduardo M. Sotomayor, MD, P.K. Epling-Burnette, PharmD, PhD, Javier Pinilla-Ibarz, MD
Journal: Blood
Blood (2010) 116 (21): 2925.
https://doi.org/10.1182/blood.V116.21.2925.2925
Published: 2010